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Letters to the Editora New York Times article describing
our work. Dr Anthony Atala has a
much better claim to this milestone
achievement.
Paolo Macchiarini, MD, PhD
Advanced Center for Translational
Regenerative Medicine
Division of Ear, Nose and Throat
Department for Clinical Science
Intervention and Technology
Karolinska Institutet
Stockholm, SwedenReferences
1. Delaere PR, Van Raemdonck D. The trachea: the
first tissue-engineered organ? J Thorac Cardiovasc
Surg. 2014;147:1128-32.
2. Gonfiotti A, Jaus MO, Barale D, Baiguera S,
Comin C, Lavorini F, et al. 5-Year follow-up of
the first tissue engineered airway transplantation.
Lancet. 2014;383:238-44.
3. Macchiarini P, Lenot B, de Montpreville V,
Dulmet E, Mazmanian GM, Fattal M, et al. Hetero-
topic pig model for direct revascularization and
venous drainage of tracheal allografts. J Thorac
Cardiovasc Surg. 1994;108:1066-75.
4. Jungebluth P, Bader A, Baiguera S, M€oller S,
JausM,LimML, et al. The concept of invivo airway
tissue engineering. Biomaterials. 2012;33:4319-26.
5. Jungebluth P, Alici E, Baiguera S, Le Blanck K,
Blomberg P, Bozoky B, et al. Tracheobronchial
transplantation with a using a stem-cell-seeded bio-
artificial nanocomposite: a proof-of-concept study.
Lancet. 2011;378:1997-2004.
http://dx.doi.org/10.1016/
j.jtcvs.2014.03.032Reply to the Editor:
We thank Dr Macchiarini for com-
menting on our editorial published in
the Journal, and we acknowledge his
team’s motivation and efforts to
advance tracheal replacement.
In his response to our editorial, Paolo
Macchiarini refers to several publica-
tions, thus undoubtedly convincing
many readers of his views. However,
in not one of these articles have morta-
lity rates been published. Furthermore,
we cannot follow his suggestion to rely
on an unpublished article to obtain this
information. Nor indeed can we refer
to its content, although we have been
in a position to read it. However, the un-
fortunate results after some of the treat-
ments with ‘‘bioengineered’’ tracheas366 The Journal of Thoracic and Chave reached investigative journalists
of Science1 and other media.2,3
More important, the purpose of our
editorial was to inform the scientific
community that regeneration of a
viable trachea resulting from applying
bone marrow cells to a decellularized
or a synthetic scaffold in the absence
of any blood supply is based on hope
and belief and not on scientific evi-
dence. None of the publications that
Macchiarini cites in his response pro-
vide scientific evidence for his claims.
We therefore strongly warn against
further unethical human experimenta-
tion. The ongoing clinical trials will
show whether or not this warning was
justified.
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j.jtcvs.2014.03.044MODIFIABLE RISK FACTORS
FOR ACUTE KIDNEY INJURY
AFTER CORONARYARTERY
BYPASS GRAFTING
To the Editor:
We read with interest the recent
article by Ng and colleagues1 that
identified modifiable risk factors
for acute kidney injury (AKI) after
coronary artery bypass grafting
(CABG) in an Asian population.
They showed that preoperative anemia
and intraoperative lowest hematocrit
were potentially modifiable risk fac-
tors independently associated withardiovascular Surgery c July 2014postoperative AKI. In the design of
this study, however, some important
data regarding patient perioperative
management, such as intraoperative
hemodynamic changes, fluid volume,
and use of vasoactive medicines,
were evidently missing. It has been
shown that intraoperative systolic
blood pressure decrease relative to
baseline is independently associated
with postoperative AKI in patients un-
dergoing CABG.2 Furthermore, the
combination of intraoperative hemodi-
lution anemia and hypotension can
synergistically act to increase the risk
of AKI after cardiac surgery.3 Camp-
bell and associates4 have demonstrated
that fluid volume before cardiopulmo-
nary bypass can contribute signifi-
cantly to intraoperative hemodilution
anemia and that restricting fluid vol-
ume before cardiopulmonary bypass
can attenuate intraoperative hemodilu-
tion anemia and decrease the need for
transfusion in patients undergoing
CABG. In addition, perioperative ino-
tropes, vasopressors, antiarrhythmics,
and diureticsmay also influence devel-
opment of AKI after cardiac surgery.
We therefore argue that optimizing
perioperative management, such as in-
traoperative avoidance of excess fluid
volume, hypotension, and renal arte-
rial vasoconstrictive drugs, should be
importantly modifiable factors in
decreasing the occurrence of postoper-
ative AKI in patients undergoing
CABG. We believe that the results of
this studywould have beenmore infor-
mative had these factors been taken
into account.
Ng and colleagues1 did not mention
the specific timing of postoperative
creatinine measurements. It was also
unclear whether continuous creatinine
measurements were performed. It is
therefore difficult to determine
whether the cases of AKI reported in
this study were due to intraoperative
or postoperative factors. Although
serum creatinine lags behind acute
changes in renal function, AKI
(defined by serum creatinine >10
mmol/L greater than normal values)
Letters to the Editorcaused by intraoperative factors can be
often detected between 1 and 3 days af-
ter surgery. Thereafter, theAKI ismore
likely to be attributable to postopera-
tive factors, such as hemodynamic
instability, anemia, transfusion, and
so on. Westenbrink and coworkers5
have found that postoperative anemia
is common after CABG, frequently
persists for months, and is associated
with impaired postoperative outcomes.
We therefore emphasize that efforts to
avoid the modifiable risk factors for
AKI should be continued in the postop-
erative period to prevent new AKI or
aggravation of existing kidney injury
by postoperative factors, especially
for patients who are at high risk for
AKI.
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j.jtcvs.2014.03.047The JournalReply to the Editor:
We thank Xue and colleagues for
their interest in our publication, in
which we showed the potential
modifiable risk factors of acute kidney
injury (AKI) after coronary artery
bypass grafting.1
The focus of this study was on
studying the effects of 3 known
modifiable risk factors, the lowest
hematocrit during cardiopulmonary
bypass (CPB), preoperative anemia,
and intraoperative red blood cell
transfusion, on postoperative AKI in
our Asian patient population with
smaller average body sized. As such,
we did not look in this study
specifically at the effects of intraope-
rative hemodynamic changes and
their potentiation of hemodilutional
anemia to result in postoperative
AKI. The intraoperative systolic
blood pressure was typically main-
tained within a tight range of 100 to
130 mm Hg, however, it is likely that
a greater decrease in systolic blood
pressure would be present in hyper-
tensive patients. We also showed a
history of hypertension to be an inde-
pendent risk factor for AKI,1 albeit an
unmodifiable factor.
We are cognizant that liberal
pre-CPB crystalloid infusion may
result in hemodilution, especially for
patients with smaller body size.
Although the pre-CPB crystalloid
infusion volume was not recorded, it
was standard practice to give no
more than 1000 mL of crystalloid
before CPB.
The influences on AKI of periope-
rative medications, such as diuretics,
inotropes, statins and antiarrhythmics,
were studied. Of these, only loop
diuretics were significantly associated
with AKI in the univariate analysis
presented in our article.1 None of
the medications were independently
associated with AKI in the multi-
variate analysis.
Inour study, postoperative creatinine
measurements were done routinely in
the intensive care unit in accordanceof Thoracic and Cardiovascular Surgewith institutional protocol. Continuous
creatinine measurements were not
done. The peak serum creatinine was
the highest creatinine value obtained
within the first 3 postoperative days
and was used to calculate against the
preoperative serum creatinine to deter-
mine whether a patient had postopera-
tive AKI. AKI was defined according
to the Acute Kidney Injury Network
(AKIN) stage 1 criteria in this study.
To compare postoperative AKI
incidence with other study cohorts,
we had to use a uniform and standard
classification of AKI. Numerous
articles have used either the RIFLE
(Risk, Injury, Failure, Loss of func-
tion, and End-stage renal disease) or
AKIN criteria to define AKI. We
chose the AKIN criteria because they
account for smaller changes in serum
creatinine, which is shown to be
associated with adverse outcomes
such as mortality.2 Moreover, the
AKIN criteria use a shorter time frame
of 48 hours to assess renal function
than the RIFLE criteria, which has a
7-day window period for AKI
diagnosis.3
We found that not only was
postoperative anemia associated with
postoperative AKI, it was indepen-
dently associated with the persistence
of AKI up until hospital discharge
(unpublished data). We therefore
agree that strategies to improve
postoperative anemia can reduce the
persistence of AKI and prevent the
subsequent development of chronic
kidney disease in cardiac surgical
patients.
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